SFHF 200
SFHF 200
Discontinued
DIN Number
02238168
Drug Class
Human
Market Date
Oct 28, 1998
Company
HC
beaumont bio-med inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02238168
AIG Number0433805001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Homeopathic
Product Specifications
Dosage FormLiquid
Route of AdministrationSublingual
AHFS Classification92:02.00*
Health Canada Classification
ACTIVE INGREDIENTS (4)
ACONITEActive
Strength: 12 X
Monograph: ACONITE
ANTIMONY POTASSIUM TARTRATEActive
Strength: 12 X
Monograph: ANTIMONY POTASSIUM TARTRATE
GELSEMIUM SEMPERVIRENSActive
Strength: 12 X
Monograph: GELSEMIUM SEMPERVIRENS
LAC VACCINUMActive
Strength: 30 X
Monograph: LAC VACCINUM